—New Peer-Reviewed Publication Highlights Phase 2 SPRING Trial Data Supporting the Disease Modifying Potential of Nebokitug in PSC and Supports Advancement to a Phase 3 Registration Trial— TEL AVIV, ...

Chemomab Therapeutics announced new findings from the Phase 2 SPRING trial that highlight the potential of their treatment, nebokitug, for primary sclerosing cholangitis (PSC) and other ...